SB357: Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)
Legislative Summary
Altering the membership of the Prescription Drug Affordability Stakeholder Council; requiring the Prescription Drug Affordability Board, under certain circumstances, to establish a process for setting upper payment limits for purchases and payor reimbursements of prescription drug products that the Board determines have led or will lead to affordability challenges; authorizing the Board to reconsider an upper payment limit for a drug that becomes a current shortage; and altering requirements related to the setting of upper payment limits.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Amendments
Favorable with Amendments 873527/1 Adopted
Favorable with Amendments 873527/1 Adopted
Floor Amendment 643725/1 (Senator West) Rejected
Floor Amendment 643725/1 (Senator West) Rejected
Floor Amendment 823025/1 (Senator West) Rejected (15-30)
Floor Amendment 823025/1 (Senator West) Rejected (15-30)
Floor Amendment 223022/1 (Senator Ready) Rejected (13-33)
Floor Amendment 223022/1 (Senator Ready) Rejected (13-33)
Favorable with Amendments 443427/1
Favorable with Amendments 443427/1